The veterinary vaccines market is projected to grow at a CAGR of 5.79% to reach US$9.279 billion by 2024, from US$6.620 billion in 2018. Increasing adoption of animal companions coupled with the growing incidence of animal diseases fuels up the growth of the market. Growth in live stocks population and increasing initiatives by the government along with the involvement of animal association widen up the market growth opportunities. Moreover, there is also a growing awareness of animal health with works as the key driver for the growth in the market. Apart from these factors, the high storage cost of vaccines acts as a restraint for the market.
This research study examines the current market trends related to demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the veterinary vaccine value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and efficient understanding of the veterinary vaccines market.
The major players profiled in the veterinary vaccines market include Elanco, Zoetis, Ceva, Merck Animal Health, and Phibro Animal Health among others.
Segmentation
The veterinary vaccines market has been analyzed through the following segments:
By Vaccine Type
Livestock Vaccines
Companion Animals Vaccines
By Technology
Live, Attenuated Vaccine
Inactivated/Killed Vaccine
Toxoid (Inactive Toxin) Vaccine
Subunit/Conjugate Vaccine
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Others
Middle East and Africa
Asia Pacific
China
Japan
India
Others
This research study examines the current market trends related to demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the veterinary vaccine value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and efficient understanding of the veterinary vaccines market.
The major players profiled in the veterinary vaccines market include Elanco, Zoetis, Ceva, Merck Animal Health, and Phibro Animal Health among others.
Segmentation
The veterinary vaccines market has been analyzed through the following segments:
By Vaccine Type
Livestock Vaccines
Companion Animals Vaccines
By Technology
Live, Attenuated Vaccine
Inactivated/Killed Vaccine
Toxoid (Inactive Toxin) Vaccine
Subunit/Conjugate Vaccine
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Others
Middle East and Africa
Asia Pacific
China
Japan
India
Others
Table of Contents
1. INTRODUCTION
2. RESEARCH METHODOLOGY
4. MARKET DYNAMICS
5. VETERINARY VACCINES MARKETBY VACCINE TYPE
6. VETERINARY VACCINES MARKET BY TECHNOLOGY
7. VETERINARY VACCINES MARKET BY GEOGRAPHY
8. COMPETITIVE INTELLIGENCE
9. COMPANY PROFILES
Companies Mentioned
- Elanco
- Zoetis
- Ceva
- Merck Animal Health
- Phibro Animal Health
- Virbac
- Hester
- Tianjin Ringpu
- Hipra
- IdtBiologika
- Jinyu Bio-Technology